Abstract: The present invention relates to compounds and methods which may be useful as treatments of neuromuscular diseases such as muscular dystrophy, and as inhibitors of NF-?B for the treatment or prevention of muscular wasting disease, including muscular dystrophy.
Abstract: The present invention relates to compounds and methods which may be useful as treatments of neuromuscular diseases such as muscular dystrophy, and as inhibitors of NF-?B for the treatment or prevention of muscular wasting disease, including muscular dystrophy.
Type:
Grant
Filed:
December 15, 2011
Date of Patent:
December 18, 2012
Assignee:
Validus Genetics
Inventors:
John M. McCall, Eric Hoffman, Kanneboyina Nagaraju
Abstract: The present invention relates to compounds and methods which may be useful as treatments of neuromuscular diseases such as muscular dystrophy, and as inhibitors of NF-?B for the treatment or prevention of muscular wasting disease, including muscular dystrophy.
Type:
Application
Filed:
December 15, 2011
Publication date:
April 19, 2012
Applicant:
VALIDUS GENETICS
Inventors:
John M. McCall, Eric Hoffman, Kanneboyina Nagaraju
Abstract: The present invention relates to compounds and methods which may be useful as treatments of neuromuscular diseases such as muscular dystrophy, and as inhibitors of NF-?B for the treatment or prevention of muscular wasting disease, including muscular dystrophy.
Type:
Application
Filed:
May 28, 2009
Publication date:
April 8, 2010
Applicant:
VALIDUS GENETICS
Inventors:
John M. McCall, Eric Hoffman, Kanneboyina Nagaraju